v3.26.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information

The following table summarizes select operating results information for each reportable segment (in thousands):

 

 

Three Months Ended
March 31,

 

 

 

2026

 

 

2025

 

Revenue

 

 

 

 

 

 

Interventional Glaucoma

 

$

18,344

 

 

$

17,114

 

Interventional Dry Eye

 

 

1,354

 

 

 

394

 

Total

 

 

19,698

 

 

 

17,508

 

Cost of goods sold

 

 

 

 

 

 

Interventional Glaucoma

 

 

2,342

 

 

 

2,298

 

Interventional Dry Eye

 

 

378

 

 

 

116

 

Total

 

 

2,720

 

 

 

2,414

 

Gross profit

 

 

 

 

 

 

Interventional Glaucoma

 

 

16,002

 

 

 

14,816

 

Interventional Dry Eye

 

 

976

 

 

 

278

 

Total

 

 

16,978

 

 

 

15,094

 

Operating expense

 

 

(29,391

)

 

 

(28,953

)

Investment income

 

 

741

 

 

 

1,148

 

Interest expense

 

 

(1,268

)

 

 

(1,263

)

Other expense, net

 

 

(29

)

 

 

(139

)

Loss before income taxes

 

$

(12,969

)

 

$

(14,113

)